(19)
(11) EP 4 380 638 A2

(12)

(88) Date of publication A3:
09.02.2023

(43) Date of publication:
12.06.2024 Bulletin 2024/24

(21) Application number: 22853864.1

(22) Date of filing: 03.08.2022
(51) International Patent Classification (IPC): 
A61L 9/20(2006.01)
A62B 23/02(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/32; C07K 16/2809; C07K 2317/31; C07K 2317/622; C07K 2317/24; C07K 2317/71; C07K 2317/524; C07K 2317/35; C07K 2317/73; C07K 2317/92; A61K 2039/505; A61K 2039/545; A61K 2039/54
(86) International application number:
PCT/US2022/039302
(87) International publication number:
WO 2023/014810 (09.02.2023 Gazette 2023/06)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 04.08.2021 US 202163229134 P

(71) Applicant: Abpro Corporation
Woburn, MA 01801 (US)

(72) Inventors:
  • LULO, James
    Woburn, Massachusetts 01801 (US)
  • MUDA, Marco
    Woburn, Massachusetts 01801 (US)
  • MURPHY, Shaun
    Woburn, Massachusetts 01801 (US)
  • PELZEK, Adam
    Woburn, Massachusetts 01801 (US)

(74) Representative: K&L Gates LLP 
Markgrafenstraße 42
10117 Berlin
10117 Berlin (DE)

   


(54) ANTI-HER2 ANTIBODIES AND USES THEREOF